СибНСХБ

Вид поиска

Область поиска

Найдено в других БД

Формат представления найденных документов:
библиографическое описание	краткий	полный

Отсортировать найденные документы по:
автору	заглавию	году издания	типу документа

Поисковый запрос: (<.>S=ХЛОРФТОРХИНОЛОНЫ<.>)

Общее количество найденных документов : 2
Показаны документы с 1 по 2

РЖ ВИНИТИ 34 (BI14) 96.01-04Б4.82

In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria [Text] / J. A. Garcia-Rodriguez [et al.] // J. Chemother. - 1995. - Vol. 7, N 3. - P189-196 . - ISSN 1120-009X
Перевод заглавия: Активность in vitro BAYy 3118 и девяти других противомикробных средств в отношении анаэробных бактерий
Аннотация: The antibacterial activity of BAY y 3118, a new chlorofluoroquinolone, was determined against 257 strains of anaerobic bacteria and compared with the activities of ofloxacin, ciprofloxacin, sparfloxacin, imipenem, cefoxitin, clindamycin, chloramphenicol, metronidazole, and ornidazole. Overall, BAY y 3118 was the most active agent tested against the Bacteroides fragilis group. Its activity (MIC[90], 0.5 mg/L) was 16-fold lower than that of sparfloxacin (MIC[90], 8 mg/L), and more than 100-fold lower than that of ofloxacin (MIC[90], 64 mg/L) and ciprofloxacin (MIC[90], 128 mg/L) against the group. No strains belonging to this group were resistant to metronidazole (MICs range, 0.12-2 mg/L) and ornidazole (MICs range, 0.12-4 mg/L). BAY y 3118 was more active than those quinolones against Prevotella and Porphyromonas spp., Fusobacterium spp., Clostridium perfringens and C. difficile (MIC[90], 0.12, 0.06, 0.12 and 0.25 mg/L, respectively). The activity of BAY y 3118 against Peptostreptococcus spp. (MIC[90], 1 mg/L) was slightly lower than that of the other Gram-positive bacteria tested. In general, BAY y 3118 was more active than cefoxitin, and it was superior to antianaerobic chemical agents like metronidazole, ornidazole and clindamycin. Pharmacokinetic and clinical trials are required to define the role of BAY y 3118 in the treatment of anaerobic infections. Испания, Hospital Univ.-Facultad de Med., Salamanca. Библ. 28

ГРНТИ	34.27.29

ВИНИТИ 341.27.29.02
Рубрики: ПРОТИВОМИКРОБНЫЕ СРЕДСТВА
BAYY 3118
АНАЭРОБНЫЕ БАКТЕРИИ
ФТОРХИНОЛОНЫ
ХЛОРФТОРХИНОЛОНЫ

Доп.точки доступа:
Garcia-Rodriguez, J.A.; Garcia-Sanchez, J.E.; Trujillano-Martin, I.; Garcia-Sanchez, E.; Garcia-Garicia, M.I.; Fresnadillo-Martinez, M.J.

РЖ ВИНИТИ 34 (BI48) 96.01-04Т2.401

In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria [Text] / J. A. Garcia-Rodriguez [et al.] // J. Chemother. - 1995. - Vol. 7, N 3. - P189-196 . - ISSN 1120-009X
Перевод заглавия: Активность in vitro BAYy 3118 и девяти других противомикробных средств в отношении анаэробных бактерий
Аннотация: The antibacterial activity of BAY y 3118, a new chlorofluoroquinolone, was determined against 257 strains of anaerobic bacteria and compared with the activities of ofloxacin, ciprofloxacin, sparfloxacin, imipenem, cefoxitin, clindamycin, chloramphenicol, metronidazole, and ornidazole. Overall, BAY y 3118 was the most active agent tested against the Bacteroides fragilis group. Its activity (MIC[90], 0.5 mg/L) was 16-fold lower than that of sparfloxacin (MIC[90], 8 mg/L), and more than 100-fold lower than that of ofloxacin (MIC[90], 64 mg/L) and ciprofloxacin (MIC[90], 128 mg/L) against the group. No strains belonging to this group were resistant to metronidazole (MICs range, 0.12-2 mg/L) and ornidazole (MICs range, 0.12-4 mg/L). BAY y 3118 was more active than those quinolones against Prevotella and Porphyromonas spp., Fusobacterium spp., Clostridium perfringens and C. difficile (MIC[90], 0.12, 0.06, 0.12 and 0.25 mg/L, respectively). The activity of BAY y 3118 against Peptostreptococcus spp. (MIC[90], 1 mg/L) was slightly lower than that of the other Gram-positive bacteria tested. In general, BAY y 3118 was more active than cefoxitin, and it was superior to antianaerobic chemical agents like metronidazole, ornidazole and clindamycin. Pharmacokinetic and clinical trials are required to define the role of BAY y 3118 in the treatment of anaerobic infections. Испания, Hospital Univ.-Facultad de Med., Salamanca. Библ. 28

ГРНТИ	34.45.21

ВИНИТИ 341.45.21.95.17
Рубрики: ПРОТИВОМИКРОБНЫЕ СРЕДСТВА
BAYY 3118
АНАЭРОБНЫЕ БАКТЕРИИ
ФТОРХИНОЛОНЫ
ХЛОРФТОРХИНОЛОНЫ

Доп.точки доступа:
Garcia-Rodriguez, J.A.; Garcia-Sanchez, J.E.; Trujillano-Martin, I.; Garcia-Sanchez, E.; Garcia-Garicia, M.I.; Fresnadillo-Martinez, M.J.

"Электронные каталоги и базы данных библиотек СО РАН"

© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)

rtvarBDview(" результаты поиска","20190607010228","4682442");

Вид поиска